Published Date: 14 Jun 2023
Researchers at the Johns Hopkins Kimmel Cancer Center are developing a novel, automated liquid biopsy test that can be used to forecast early disease progression and potential survival among patients with metastatic breast cancer.
Read Full NewsFindings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation